FDA Investigator Kin T Moy
Kin T Moy has conducted inspections on 15 sites in 1 countries as of 17 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
17 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kin T Moy:
Adam S Freeman,
Aimee K Contreras,
Alice A Blair,
Angel K Sandhu,
Breena L D'ambrogi,
Bruce D Broidy,
Capri R Woolridge,
Cathryn M Groehnert,
Celeste K Wong,
Christine M Parmentier,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Daniel J Roberts,
David A Lum,
Debra D Devlieger,
Edna J Hidalgo,
Elodie X Tong Lin,
Eric J Heinze,
Geoffrey M Leist,
Gillenwater,
Greg K Keshishyan,
Huy T Pham,
Ismael Garibay,
Janice R Small,
Janice Wai,
Jazmine M Welcher,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jessica M Monteiro,
John A Liu,
John Cheung,
Jolene S Hedgecock,
Juan A Morales,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karla J Gibler,
Keren Arkin,
Kevin P Foley,
Larkin R Buckalew,
Lawton W Lum,
Lija V Fellows,
Lilia K Vazquez,
Lisa H Nakagawa,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lydia S Chan,
Maida Henesian (NMI),
Mark I Nakano,
Mary C Wall,
Mcgrewp,
Monique C Lo,
Muoi N Hoang,
Nicolas C Tolosa, III,
Nicole Yuen,
Phung,
Quynh H Strandberg,
Randall P Zielinski,
Rashonda N Rucker,
Riley C Graham,
Roberta K Smith,
Roger D Gawne,
Ronald P Boyce,
Sabino S Camacho,
Sandra S Saniga,
Savannah E Samp,
Sean P Desbrow,
Steve P Yost,
Steven B Chiu,
Steven M Galvez,
Terrence Gee,
Tiffany Chao,
Travelle D Mason,
Victoria L Morgan,
Wayne L Jefferson,
Wen Jun Peng,
Wendy S Shenk,
William J Foust,
William J Weis,
William V Millar,
Zachary Ryan Harris
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more